About AllCells
AllCells is a company based in Alameda (United States) founded in 1998 was acquired by Discovery Life Sciences in July 2022. The company has 58 employees. AllCells offers products and services including Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood. AllCells operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Alameda, United States
- Employees 58
- SectorsHealthcare
- Website allcells.com
- Social LinkedIn X Facebook
- Acquired by Discovery Life Sciences (Jul 2022)
- Legal Name Allcells Llc
- Latest Funding Round$220.31K (USD), Grant
Sep 2015
- InvestorsHHS
& 1 more
- Employee Count58
- Acquired byDiscovery Life Sciences
(Jul 2022)
Products & Services of AllCells
AllCells offers a comprehensive portfolio of products and services, including Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood.
Offers large-scale yield of CD34+ cells for research purposes.
Provides preserved cells for cell and gene therapy studies.
Supplies fresh aspirate for hematological research applications.
Delivers CD34+ cells from donors for therapy development.
Funding Insights of AllCells
- Total Rounds 1
- Last Round Grant — $220,314
- First Round $220,314
(Sep 2015)
- Investors Count 1
All 1 funding rounds of AllCells with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $220,314 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in AllCells
AllCells has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Discovery Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Provider of diversified services with integrated technology platforms for drug discovery | 2006 | dls.com | Huntsville, United States |
Investor details for AllCells
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AllCells
12 people are tracked at AllCells (6 in leadership, 6 in team); the tracked headcount is 58.
| Name | Role | Group |
|---|---|---|
Eric Lau | Director Of Manufacturing | Leadership |
Jay Tong | Founder, President, and CEO | Leadership |
Karen Bostwick | Sr. Business Development Director | Leadership |
Lisa Martin | Director, Sales | Leadership |
Conor Marino | Business Development Director | Leadership |
Angela Martinovic | Business Development Director | Cell & Gene Therapy | Leadership |
Nai Saechao | Operations Specialist I | Team |
Carla Velez | Cell Processing Specialist Lll - CGT | Team |
Cathline Arellano | Quality Assurance Specialist | Team |
Calvin Middleton | Operations Supervisor | Team |
Candace Calhoun | Donor Recruiter | Team |
Susie Wong | Cell Processing Lab Manager | Team |
Complete people profiles for AllCells
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AllCells
3 dated milestones of AllCells across 24 years, from founding to its latest funding, stage changes and deals.
- Founded AllCells is founded.
- Funding First funding round of $220K.
- Exit Acquired by Discovery Life Sciences.
Competitors of AllCells
AllCells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of AllCells
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AllCells
The website of AllCells (allcells.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▲ 11.4% vs previous month
Websites whose visitors overlap most with AllCells. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bionanogenomics.com | 100% | – | #4,512,022 | View details | |
| caltagmedsystems.co.uk | 88% | – | #1,664,753 | View details | |
| biocare.net | 85% | 23.2K | #1,197,634 | View details | |
| amaxa.com | 77% | – | – | View details | |
| cellbiologics.com | 77% | 6.9K | #3,218,171 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for AllCells
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Allcells
Complete news archive for AllCells
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to AllCells
10 companies that operate in the same segment as AllCells (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AllCells
AllCells was founded in 1998 and raised its 1st funding round 17 years after it was founded.
AllCells is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
AllCells has 58 employees.
AllCells was founded in 1998 and is based in Alameda, United States. Primary cells from human and animal sources, including stem cells derived from bone marrow, peripheral blood, mobilized peripheral blood, cord blood, diseased tissues, and non-human primates, are supplied by the company. Associated media, cytokines, reagents, and biological research services are also offered within the biotechnology sector focused on cell-based research.
AllCells's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
AllCells offers Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood.
AllCells has 2 investors. Key investors include HHS, and Discovery Life Sciences.
AllCells operates through Allcells Llc.
Yes. AllCells was acquired by Discovery Life Sciences in July 2022.